How Mantis Biotech Is Using Digital Twins to Transform Modern Medicine

Medicine is going into a phase where computer models of people help doctors make decisions about real patients. Mantis Biotech is leading the way by creating computer models that are very similar to real patients. These computer models, called twins, help scientists learn about diseases without having to wait for information from real patients. This means that new ideas and treatments can be developed faster and more accurately.

To start, the company makes computer copies of patients using information about their bodies, genes, and how they live. These models actase patients would in different situations. So scientists can see how diseases progress or how patients might respond to treatments. By just using information from a small number of patients, they can try out many different scenarios quickly and safely.

This approach also solves a problem in medicine: not having enough good information to work with. Usually, researchers have to work with groups of patients and have to consider ethical issues. Digital twins make it possible to get more information without putting patients in danger. As a result, researchers can learn more. Still do what is right.

Also, developing drugs becomes faster and more efficient with these computer models. Companies can test treatments on simulated patients before trying them on real people. This means that fewer new drugs will fail, and it will cost less to develop them. So new treatments can get to patients who need them sooner.

At the time, this technology is very good for personalized medicine. Doctors can look at a computer model of a patient to see how they might respond to treatments. Then they can adjust the treatment based on what’s likely to work best. This approach is more accurate. Reduces bad side effects.

In the end, Mantis Biotech is showing how technology can change the future of healthcare. With digital twins making research and care smarter, medicine is becoming more about preventing diseases and treating patients as individuals. Looking ahead, this change might completely alter how we prevent, diagnose, and treat diseases around the world.